Novel insight into the distribution of L-cells in the rat intestinal tract

American Journal of Translational Research

Volumn 5, Issue 3, 2013, Pages 347-358

  Hansen, Carl Frederik ^a,b   Vrang, Niels ^a   Torp Sangild, Per ^b   Jelsing, Jacob ^a  

^a Gubra ApS   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Diabetes; GLP 1; L cell; Stereology; ZDF

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; PREPROGLUCAGON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELLULAR DISTRIBUTION; COLON; CONTROLLED STUDY; DECAPITATION; DIABETES MELLITUS; ENDOCRINE CELL; HISTOLOGY; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE; JEJUNUM; L CELL; NONHUMAN; OBESITY; RAT; STOMACH BYPASS; ZUCKER DIABETIC FATTY RAT;

RATTUS;

EID: 84877082830     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Sjostrom L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond) 2008; 32 Suppl 7: S93-97.
2. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM and et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-350; discussion 350-352.
3. Kim S and Richards WO. Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gas-tric bypass. Ann Surg 2010; 251: 1049-1055.
4. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP and Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256, e245.
5. Tharakan G, Tan T and Bloom S. Emerging therapies in the treatment of 'diabesity': beyond GLP-1. Trends Pharmacol Sci 2011; 32: 8-15.
6. Rhee NA, Vilsboll T and Knop FK. Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes. Diabetes Obes Metab 2012; 14: 291-298.
7. Bryant MG and Bloom SR. Distribution of the gut hormones in the primate intestinal tract. Gut 1979; 20: 653-659.
8. Evans GS and Potten CS. The distribution of endocrine cells along the mouse intestine: a quantitative immunocytochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 1988; 56: 191-199.
9. Barbosa AJ, Nogueira JC, Penna FJ and Polak JM. Distribution of enteroglucagon and polypeptide YY-immunoreactive cells in the gastrointestinal tract of the white-belly opossum (Didelphis albiventris). Histochemistry 1987; 88: 37-40.
10. Mortensen K, Christensen LL, Holst JJ and Orskov C. GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 2003; 114: 189-196.
11. Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R and Goke B. Glucagon-like 356 peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 1992; 22: 283-291.
12. Grigoryan M, Kedees MH, Charron MJ, Guz Y and Teitelman G. Regulation of Mouse Intestinal L Cell Progenitors Proliferation by the Glucagon Family of Peptides. Endocrinology 2012 Jul; 153: 3076-88.
13. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439.
14. Drucker DJ. The biology of incretin hormones. Cell Metab 2006; 3: 153-165.
15. Pinto HC, Portela-Gomes GM, Grimelius L, Kohnert KD, de Sousa JC and Albuquerque MA. The distribution of endocrine cell types of the gastrointestinal mucosa in genetically diabetic (db/db) mice. Gastroenterology 1995; 108: 967-974.
16. Rocca AS and Brubaker PL. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999; 140: 1687-1694.
17. Nauck MA, Vardarli I, Deacon CF, Holst JJ and Meier JJ. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011; 54: 10-18.
18. Varndell IM, Bishop AE, Sikri KL, Uttenthal LO, Bloom SR and Polak JM. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 1985; 33: 1080-1086.
19. Balks HJ, Holst JJ, von zur Muhlen A and Brabant G. Rapid oscillations in plasma glucagonlike peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. J Clin Endocrinol Metab 1997; 82: 786-790.
20. Nauck MA, Siemsgluss J, Orskov C and Holst JJ. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections. Z Gastroenterol 1996; 34: 159-166.
21. Herrmann C, Goke R, Richter G, Fehmann HC, Arnold R and Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 1995; 56: 117-126.
22. Ghatei MA, Uttenthal LO, Christofides ND, Bryant MG and Bloom SR. Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract. J Clin Endocrinol Metab 1983; 57: 488-495.
23. Gundersen HJ and Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987; 147: 229-263.
24. Gundersen HJ, Jensen EB, Kieu K and Nielsen J. The efficiency of systematic sampling in stereology--reconsidered. J Microsc 1999; 193: 199-211.
25. Van Ginneken C, Van Meir F and Weyns A. Stereologic characteristics of pig small intestine during normal development. Dig Dis Sci 2002; 47: 868-878.
26. Mayhew TM, Elbrond VS, Dantzer V, Skadhauge E and Moller O. Structural and enzymatic studies on the plasma membrane domains and sodium pump enzymes of absorptive epithelial cells in the avian lower intestine. Cell Tissue Res 1992; 270: 577-585.
27. Mayhew TM. Geometric model of the rat intestinal mucosa for stereological evaluation of villus amplification factors. J Microsc 1984; 135: 337-346.
28. Mikkelsen HB, Larsen JO, Froh P and Nguyen TH. Quantitative Assessment of Macrophages in the Muscularis Externa of Mouse Intestines. Anat Rec (Hoboken) 2011; Epub ahead of print.
29. Pakkenberg B and Gundersen HJ. Total number of neurons and glial cells in human brain nuclei estimated by the disector and the fractionator. J Microsc 1988; 150: 1-20.
30. Orskov C, Holst JJ, Knuhtsen S, Baldissera FG, Poulsen SS and Nielsen OV. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 1986; 119: 1467-1475.
31. Vrang N, Hansen M, Larsen PJ and Tang-Christensen M. Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei. Brain Res 2007; 1149: 118-126.
32. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 1984; 134: 127-136.
33. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B and et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988; 96: 857-881.
34. Karlsen AS and Pakkenberg B. Total numbers of neurons and glial cells in cortex and basal ganglia of aged brains with Down syndrome--a stereological study. Cereb Cortex 2011; 21: 2519-2524.
35. Kristensen P, Eriksen J and Dano K. Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J Histochem Cytochem 1991; 39: 341-349.
36. Vrang N, Larsen PJ, Jensen PB, Lykkegaard K, Artmann A, Larsen LK and Tang-Christensen M. Upregulation of the brainstem preproglucagon system in the obese Zucker rat. Brain Res 2008; 1187: 116-124.
37. Bock T, Svenstrup K, Pakkenberg B and Buschard K. Unbiased estimation of total beta-cell number and mean beta-cell volume in rodent pancreas. APMIS 1999; 107: 791-799.
38. Polak JM, Bloom S, Coulling I and Pearse AG. Immunofluorescent localization of enteroglucagon cells in the gastrointestinal tract of the dog. Gut 1971; 12: 311-318.
39. Yamada J, Tauchi M, Rerkamnuaychoke W, Endo H, Chungsamarnyart N, Kimura J, Kurohmaru M, Hondo E, Kitamura N, Nishida T and Hayashi Y. Immunohistochemical survey of the gut endocrine cells in the common tree shrew (Tupaia belangeri). J Vet Med Sci 1999; 61: 761-767.
40. O'Brien RM and Granner DK. Regulation of gene expression by insulin. Physiol Rev 1996; 76: 1109-1161.
41. Cani PD, Hoste S, Guiot Y and Delzenne NM. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 2007; 98: 32-37.
42. Van Ginneken C, Verlinden K, Van Meir F, Sys S and Weyns A. A stereologic evaluation of glucagon-like peptide-1 (GLP-1) mucosal cells in the small intestine of the developing pig. Anat Embryol (Berl) 2002; 205: 153-157.
43. Berghofer P, Peterson RG, Schneider K, Fehmann HC and Goke B. Incretin hormone expression in the gut of diabetic mice and rats. Metabolism 1997; 46: 261-267.
44. Anini Y and Brubaker PL. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 2003; 52: 252-259.
45. Williams DL, Baskin DG and Schwartz MW. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 2006; 55: 3387-3393.
46. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J and Marks V. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993; 138: 159-166.
47. Roberge JN and Brubaker PL. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 1993; 133: 233-240.
48. de Wit NJ, Bosch-Vermeulen H, de Groot PJ, Hooiveld GJ, Bromhaar MM, Jansen J, Muller M and van der Meer R. The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Med Genomics 2008; 1: 14.
49. Cummings BP, Strader AD, Stanhope KL, Graham JL, Lee J, Raybould HE, Baskin DG and Havel PJ. Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology 2010; 138: 2437-2446, e2431.
50. Bueter M, Lowenstein C, Olbers T, Wang M, Cluny NL, Bloom SR, Sharkey KA, Lutz TA and le Roux CW. Gastric bypass increases energy expenditure in rats. Gastroenterology 2010; 138: 1845-1853.
51. Brubaker PL, Izzo A, Hill M and Drucker DJ. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol 1997; 272: E1050-1058.
52. Drucker DJ, Erlich P, Asa SL and Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 1996; 93: 7911-7916.
53. Litvak DA, Hellmich MR, Evers BM, Banker NA and Townsend CM Jr. Glucagon-like peptide 2 is a potent growth factor for small intestine and colon. J Gastrointest Surg 1998; 2: 146-150.
54. Jin X, Zimmers TA, Zhang Z, Pierce RH and Koniaris LG. Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut 2010; 59: 186-196.
55. Viguera RM, Rojas-Castaneda J, Hernandez R, Reyes G and Alvarez C. Histological characteristics of the intestinal mucosa of the rat during the first year of life. Lab Anim 1999; 33: 393-400.
56. Bertoni S and Gabella G. Hypertrophy of mucosa and serosa in the obstructed intestine of rats. J Anat 2001; 199: 725-734.
57. Stearns AT, Balakrishnan A and Tavakkolizadeh A. Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. Am J Physiol Gastrointest Liver Physiol 2009; 297: G950-957.
58. Sukhotnik I, Shamir R, Bashenko Y, Mogilner JG, Chemodanov E, Shaoul R, Coran AG and Shehadeh N. Effect of oral insulin on diabetesinduced intestinal mucosal growth in rats. Dig Dis Sci 2011; 56: 2566-2574.
59. Mayhew TM and Middleton C. Crypts, villi and microvilli in the small intestine of the rat. A stereological study of their variability within and between animals. J Anat 1985; 141: 1-17.
60. Habib AM, Richards P, Cairns LS, Rogers GJ, Bannon CA, Parker HE, Morley TC, Yeo GS, Reimann F and Gribble FM. Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 2012; 153: 3054-3065.
61. Egerod KL, Engelstoft MS, Grunddal KV, Nohr MK, Secher A, Sakata I, Pedersen J, Windelov JA, Fuchtbauer EM, Olsen J, Sundler F, Christensen JP, Wierup N, Olsen JV, Holst JJ, Zigman JM, Poulsen SS and Schwartz TW. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 2012; 153: 5782-5795.
62. Gribble FM. The gut endocrine system as a coordinator of postprandial nutrient homoeostasis. Proc Nutr Soc 2012; 71: 456-462.
63. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L and Kelley D. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484; discussion 484-485.
64. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG and Bloom SR. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108-114.
65. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL and Wardlaw SL. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005; 90: 359-365.
66. Vincent RP and le Roux CW. Changes in gut hormones after bariatric surgery. Clin Endocrinol (Oxf) 2008; 69: 173-179.